SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-07-008585
Filing Date
2007-08-21
Accepted
2007-08-21 08:00:19
Documents
2
Period of Report
2007-08-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS, INC. a5475605.txt 8-K 4899
2 EXHIBIT 99.1 a5475605ex99-1.txt EX-99.1 6070
  Complete submission text file 0001157523-07-008585.txt   12634
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 071069423
SIC: 2835 In Vitro & In Vivo Diagnostic Substances